Wiyono Lowilius, Ghitha Nida, Clarisa Dina, Larasati Anjani
Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Ann Pediatr Endocrinol Metab. 2023 Sep;28(3):206-214. doi: 10.6065/apem.2244242.121. Epub 2023 Sep 19.
Type 1 diabetes mellitus, which is the most common type of diabetes among children, is not curable but can be managed well without a negative effect on quality of life. One of the treatments of type 1 diabetes mellitus is carbohydrate counting. This systematic review and meta-analysis sought to evaluate the efficacy of carbohydrate counting with regard to hemoglobin A1c (HbA1c) reduction in children with type 1 diabetes mellitus.
Nine studies were assessed, with the primary outcome being glycemic control (HbA1c changes). We searched the following electronic databases: ProQuest, PubMed, Scopus, and ScienceDirect. The quality of studies included was assessed using the risk of bias for randomized control trials and the JBI Critical Appraisal Checklist for observational and cross-sectional studies. Quantitative analyses were made and extrapolated into a forest plot.
A total of 1,693 articles were identified. Four reviewers independently screened titles and abstracts. Of the 36 articles screened, 34 articles were found to be eligible. Of these, 25 studies were excluded because of unsuitable outcomes and study designs. Nine articles were included in the final analysis. Meta-analysis showed that there was a reduction in HbA1c in the carbohydrate counting group as compared to the control group. The cumulative effect of carbohydrate counting on HbA1c was a mean difference of -0.55 (95% confidence interval, -0.81 to -0.28, P<0.001). All of the studies exhibited similar results with the mean difference reduction favoring the interventional group. However, the heterogeneity analysis revealed an I2 value of 88%, implying high heterogeneity in the meta-analysis.
The meta-analysis showed evidence favoring the use of carbohydrate counting in the management of type 1 diabetes mellitus.
1型糖尿病是儿童中最常见的糖尿病类型,无法治愈,但可以得到良好管理,且对生活质量无负面影响。碳水化合物计数是1型糖尿病的治疗方法之一。本系统评价和荟萃分析旨在评估碳水化合物计数对1型糖尿病儿童糖化血红蛋白(HbA1c)降低的疗效。
评估了9项研究,主要结局为血糖控制(HbA1c变化)。我们检索了以下电子数据库:ProQuest、PubMed、Scopus和ScienceDirect。使用随机对照试验的偏倚风险以及观察性和横断面研究的JBI批判性评价清单对纳入研究的质量进行评估。进行了定量分析并外推到森林图中。
共识别出1693篇文章。四名评审员独立筛选标题和摘要。在筛选的36篇文章中,发现34篇符合条件。其中,25项研究因结局和研究设计不合适而被排除。最终分析纳入了9篇文章。荟萃分析表明,与对照组相比,碳水化合物计数组的HbA1c有所降低。碳水化合物计数对HbA1c的累积效应平均差异为-0.55(95%置信区间,-0.81至-0.28,P<0.001)。所有研究均呈现相似结果,平均差异降低有利于干预组。然而,异质性分析显示I2值为88%,这意味着荟萃分析中存在高度异质性。
荟萃分析表明有证据支持在1型糖尿病管理中使用碳水化合物计数。